The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase II, single-arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with advanced esophageal carcinoma.
A. Chatterjee
No relevant relationships to disclose
J. Biswas
No relevant relationships to disclose
S. Bhattacharya
No relevant relationships to disclose
A. K. Chatterjee
No relevant relationships to disclose
A. Chakraborty
No relevant relationships to disclose
R. S. Bhakta
No relevant relationships to disclose